Favorable Early Outcomes After Simultaneous Heart-Kidney Transplantation from a Donor with Fabry Disease (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #SA-PO1213; Pres time: Oct 24, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "The donor was a 22-year-old male with known Fabry disease previously treated with agalsidase beta but nonadherent to therapy who died from suicide...Immunosuppression included basiliximab induction and maintenance with tacrolimus, mycophenolate, and prednisone...Prior reports suggest histologic Fabry inclusions may persist following transplantation from affected donors despite preserved graft function. Carefully selected organs from young donors with Fabry disease and minimal chronic structural injury may represent an opportunity to safely expand the donor pool while maintaining acceptable renal allograft outcomes."
Cardiomyopathy • Cardiovascular • Chronic Kidney Disease • Fabry Disease • Genetic Disorders • Lysosomal Storage Diseases • Metabolic Disorders • Nephrology • Rare Diseases • Transplantation
|
|
Kamil Sardarli; Shana M. Coley; Syed Ali Husain; Aprajita Mattoo
|